SkinTE

BIOLOGICAL3 trials

Sponsors

PolarityTE

Conditions

DFUDiabetic FootDiabetic Foot DiseaseNeuropathic Diabetic Ulcer - Foot

Phase 3

Multi-Center, Prospective, Randomized Controlled Trial Evaluating SkinTE® in the Treatment of Wagner 2 DFUs

TerminatedNCT05372809

PolarityTEDiabetic Foot

Start: 2022-04-28End: 2024-02-21Updated: 2024-02-26

SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)

Active, not recruitingNCT06140303

PolarityTEDiabetic Foot

Start: 2024-02-22End: 2026-03-31Target: 100Updated: 2025-07-11

Unknown Phase

Expanded Access Program Evaluating SkinTE in the Treatment of Wagner 1 Diabetic Foot Ulcers

PolarityTEDFU, Diabetic Foot Disease, Neuropathic Diabetic Ulcer - Foot

Updated: 2025-10-30